Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence
- PMID: 6332167
- PMCID: PMC2187458
- DOI: 10.1084/jem.160.2.521
Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence
Abstract
We studied the mechanism of lymphocytic choriomeningitis virus (LCMV) persistence and the suppression of cytotoxic T lymphocyte (CTL) responses in BALB/c WEHI mice infected at birth with LCMV Armstrong strain. Using adoptive transfer experiments we found that spleen cells from persistently infected (carrier) mice actively suppressed the expected LCMV-specific CTL response of spleen cells from normal adult mice. The suppression was specific for the CTL response and LCMV -specific antibody responses were not affected. Associated with the specific CTL suppression was the establishment of persistent LCMV infection. The transfer of spleen or lymph node cells containing LCMV -specific CTL resulted in virus clearance and prevented establishment of the carrier state. The suppression of LCMV -specific CTL responses by carrier spleen cells is not mediated by a suppressor cell, but is due to the presence of genetic variants of LCMV in spleens of carrier mice. Such virus variants selectively suppress LCMV-specific CTL responses and cause persistent infections in immunocompetent mice. In striking contrast, wild-type LCMV Armstrong, from which these variants were generated, induces a potent CTL response in immunocompetent mice and the LCMV infection is rapidly cleared. Our results show that LCMV variants that emerge during infection in vivo play a crucial role in the suppression of virus-specific CTL responses and in the maintenance of virus persistence.
Similar articles
-
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.J Immunol. 1986 Jan;136(2):698-704. J Immunol. 1986. PMID: 2416821
-
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.J Virol. 1994 Dec;68(12):8056-63. doi: 10.1128/JVI.68.12.8056-8063.1994. J Virol. 1994. PMID: 7966595 Free PMC article.
-
Organ-specific selection of viral variants during chronic infection.J Exp Med. 1988 May 1;167(5):1719-24. doi: 10.1084/jem.167.5.1719. J Exp Med. 1988. PMID: 3367096 Free PMC article.
-
Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice.Ann N Y Acad Sci. 1988;532:238-56. doi: 10.1111/j.1749-6632.1988.tb36343.x. Ann N Y Acad Sci. 1988. PMID: 3052209 Review. No abstract available.
-
Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model.Immunogenetics. 2001 Apr;53(3):185-9. doi: 10.1007/s002510100314. Immunogenetics. 2001. PMID: 11398962 Review.
Cited by
-
Type I interferon induced during chronic viral infection favors B-cell development in the thymus.Immunol Cell Biol. 2024 Oct;102(9):801-816. doi: 10.1111/imcb.12808. Epub 2024 Jul 15. Immunol Cell Biol. 2024. PMID: 39009814
-
Retinal microglia express more MHC class I and promote greater T-cell-driven inflammation than brain microglia.Front Immunol. 2024 May 10;15:1399989. doi: 10.3389/fimmu.2024.1399989. eCollection 2024. Front Immunol. 2024. PMID: 38799448 Free PMC article.
-
Neuroretinal degeneration in a mouse model of systemic chronic immune activation observed by proteomics.Front Immunol. 2024 Apr 11;15:1374617. doi: 10.3389/fimmu.2024.1374617. eCollection 2024. Front Immunol. 2024. PMID: 38665911 Free PMC article.
-
CD8+ T Cells Mediate Lethal Lung Pathology in the Absence of PD-L1 and Type I Interferon Signalling following LCMV Infection.Viruses. 2024 Mar 1;16(3):390. doi: 10.3390/v16030390. Viruses. 2024. PMID: 38543756 Free PMC article.
-
Autoimmunity-associated allele of tyrosine phosphatase gene PTPN22 enhances anti-viral immunity.PLoS Pathog. 2024 Mar 21;20(3):e1012095. doi: 10.1371/journal.ppat.1012095. eCollection 2024 Mar. PLoS Pathog. 2024. PMID: 38512979 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources